Chemi Nutra's new study may be the first of its kind.
Chemi Nutra (White Bear Lake, MN) has published what it believes is the first clinical study to investigate phosphatidic acid supplementation for exercise performance. Researchers believe that phosphatidic acid can stimulate mammalian target of rapamycin (mTOR), which may be necessary for mechanical load-induced growth of skeletal muscle and resulting strength gains.
During an eight-week resistance-training program, 20 young men were assigned to 750 mg of Monitor phosphatidic acid or 750 mg of a rice flour placebo daily. Subjects were instructed to perform one maximum repetition of a bench press and leg squat to assess maximum strength. Body composition and diet was evaluated daily.
Compared to placebo users, subjects who consumed Monitor phosphatidic acid demonstrated significantly increased squat strength, bench press strength, and lean muscle (an increase of 2.6% compared to 0.1%).
Chemi Nutra’s study is now published in the Journal of the International Society of Sports Nutrition.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.